Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

pirarubicin

An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent is less cardiotoxic than doxorubicin and exhibits activity against some doxorubicin-resistant cell lines.
Synonym:Tepirubicin
tetrahydropyranyl-doxorubicin
theprubicin
THP-Adriamycin
THP-doxorubicin
Foreign brand name:Pinorubicin
Theprubicine
Therarubicin
Abbreviation:THP-ADM
THP-DOX
Code name:1609-RB
1609RB
Chemical structure:(2"R)-4'-O-tetrahydropyranyladriamycin
(8S,10S)-10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-3-yl)-alpha-L-lyxo-hexopyranosyl]oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
[8S-[8alpha,10alpha(S*)]]-10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
4'-O-tetrahydropyranyl doxorubicin
Search NCI's Drug Dictionary